The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
NF-κB Signaling Pathway, Inflammation and Colorectal Cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Signal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Herrero, R. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg107 · Cited by 1,228
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Solomon, S. D., Kim, K., Tang, J., Rosenstein, R. B., Wittes, J., Corle, D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061355 · Cited by 1,048
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Li, Z.-W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., & Karin, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1839 · Cited by 926
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Weir, H. K. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg040 · Cited by 867
Anti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862
Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100
Xiao, G., Harhaj, E. W., & Sun, S.-C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 834
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 781
To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis
Kucharczak, J., Simmons, M. J., Fan, Y., & Gélinas, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207230 · Cited by 769
The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-x L
Chen, C., Edelstein, L. C., & Gélinas, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2687-2695.2000 · Cited by 760
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Gross, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715
Inflammation and necrosis promote tumour growth
Vakkila, J., & Lotze, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1415 · Cited by 690
NF-κB and cancer — identifying targets and mechanisms
Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Hostile takeovers: viral appropriation of the NF-kB pathway
Hiscott, J., Kwon, H., & Génin, P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11918 · Cited by 613
Luo, J.-L., Maeda, S., Hsu, L.-C., Yagita, H., & Karin, M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.012 · Cited by 603
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice
Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35073 · Cited by 548
NF-κB, chemokine gene transcription and tumour growth
Richmond, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri887 · Cited by 523
Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia
Schottenfeld, D., & Beebe-Dimmer, J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.69 · Cited by 475
Seril, D. N. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.353 · Cited by 467
CD40 regulates the processing of NF-kappaB2 p100 to p52
Coope, H. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf542 · Cited by 440
Farrow, D. C., Vaughan, T. L., Hansten, P. D., et al. (1998) · PubMed · Cited by 416
Terpenoids: natural inhibitors of NF-κB signaling with anti-inflammatory and anticancer potential
Salminen, A., Lehtonen, M., Suuronen, T., Kaarniranta, K., & Huuskonen, J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8103-5 · Cited by 406
Cancer and infection: estimates of the attributable fraction in 1990.
Pisani, P., Parkin, D. M., Muñóz, N., & Ferlay, J. (1997) · PubMed · Cited by 388
Dejardin, E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.007 · Cited by 344
CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response
Kato, T., Delhase, M., Hoffmann, A., & Karin, M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00358-7 · Cited by 314
Inflammation by remote control
Mantovani, A. (2005) · Nature · doi:10.1038/435752a · Cited by 313
Weber, C. K., Liptay, S., Wirth, T., Adler, G., & Schmid, R. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19458 · Cited by 299
Tsurutani, J., Castillo, S. S., Brognard, J., Granville, C. A., Zhang, C., Gills, J. J., Sayyah, J., & Dennis, P. A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi072 · Cited by 291
Huang, S., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · PubMed · Cited by 250
NF‐κB as a potential molecular target for cancer therapy
Lee, C. H., Jeon, Y., Kim, S., & Song, Y. (2007) · BioFactors · doi:10.1002/biof.5520290103 · Cited by 248
IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis
Senftleben, U., Li, Z.-W., Baud, V., & Karin, M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00104-2 · Cited by 207
Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation
Majumdar, S., & Aggarwal, B. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2911 · Cited by 192
NF-κB in cancer—a friend turned foe
Ravi, R. K., & Bedi, A. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.003 · Cited by 174
Chronic inflammation, immunosuppression and cancer: New insights and outlook
Baniyash, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.12.002 · Cited by 160
Derudder, E., Dejardin, E., Pritchard, L. L., Green, D. R., Körner, M., & Baud, V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300106200 · Cited by 160
Inflammation and Cancer: A Double-Edged Sword
Hagemann, T., Balkwill, F. R., & Lawrence, T. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.005 · Cited by 157
Ziegelbauer, K. B., Gantner, F., Lukacs, N. W., Berlin, A. A., Fuchikami, K., Niki, T., Sakai, K., Inbe, H., Takeshita, K., Ishimori, M., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706176 · Cited by 147
Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer
Fernández‐Majada, V., Aguilera, C., Villanueva, A., Vilardell, F., Robert‐Moreno, A., Aytés, À., Real, F. X., Capellá, G., Mayo, M. W., Espinosa, L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606476104 · Cited by 145
Frelin, C. (2004) · Blood · doi:10.1182/blood-2004-04-1463 · Cited by 142
Ardite, E., Panés, J., Miranda, M., Salas, A., Elizalde, J., Sans, M., Arce, Y., Bordas, J. M., Fernández-Checa, J. C., & Pique, J. M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701887 · Cited by 119
Markers of inflammation and risk of ovarian cancer in Los Angeles County
Wu, A. H., Pearce, C. L., Tseng, C., Templeman, C. E., & Pike, M. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.24091 · Cited by 107
Chemopreventive Agents Induce Suppression of Nuclear Factor‐κB Leading to Chemosensitization
Bharti, A. C., & Aggarwal, B. B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04671.x · Cited by 98
Choo, M., Sakurai, H., Kim, D., & Saiki, I. (2008) · Oncology Reports · doi:10.3892/or.19.3.595 · Cited by 91
Yu, M., Yeh, J., & Waes, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3758 · Cited by 78
Chan, C.-F., Yau, T.-O., Jin, D., Wong, C., Fan, S.-T., & Ng, I. O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0574 · Cited by 75
Schottenfeld, D., & Beebe‐Dimmer, J. (2004) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144402 · Cited by 71
Tang, R., Wang, J., Lo, S. K., & Hsieh, L. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990812)82:4<473::aid-ijc1>3.0.co;2-k · Cited by 70
Frelin, C., Imbert, V., Griessinger, E., Loubat, A., Dréano, M., & Peyron, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206963 · Cited by 67
Blocking anti‐apoptosis as a strategy for cancer chemotherapy: NF‐κB as a target
Monks, N. R., Biswas, D. K., & Pardee, A. B. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20080 · Cited by 64
Tew, G. W., Lorimer, E., Berg, T. J., Zhi, H., Li, R., & Williams, C. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707526200 · Cited by 60
Non-steroidal anti-inflammatory drugs and colorectal cancer prevention
Sangha, S., Yao, M., & Wolfe, M. M. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2003.008227 · Cited by 29
Different modes of NF-κB/Rel activation in pancreatic lobules
Algül, H., Tando, Y., Beil, M., Weber, C. K., von Weyhern, C., Schneider, G., Adler, G., & Schmid, R. M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00407.2001 · Cited by 28
Do Older Adults Using NSAIDs Have a Reduced Risk of Colorectal Cancer?
Hoffmeister, M., Chang-Claude, J. C., & Brenner, H. (2006) · Drugs & Aging · doi:10.2165/00002512-200623060-00006 · Cited by 10
Cited by
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Inflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 551
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Cytoplasmic vacuolization in cell death and survival
Shubin, A. V., Demidyuk, I. V., Komissarov, A. A., Rafieva, L. M., & Kostrov, S. V. (2016) · Oncotarget · doi:10.18632/oncotarget.10150 · Cited by 372
Ladoire, S., Martin, F., & Ghiringhelli, F. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1046-y · Cited by 331
Metadata
- Authors
- Wang, S., Liu, Z., Wang, L., & Zhang, X.
- Venue
- Cellular & Molecular Immunology
- Published
- 2009-10-01
- Volume
- 6
- Issue
- 5
- Pages
- 327-334
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- OpenAlex
- W2007691970
- Cited by
- 405
- References
- 84
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.